Table 3.
Univariate analysis.
Parameters | Hazard ratio | DFS 95% CI | P-value | Hazard ratio | OS 95% CI | P-value |
---|---|---|---|---|---|---|
Age, years (≤60 VS >60) | 0.782 | (0.589, 0.989) | 0.210 | 0.887 | (0.699-1.204) | 0.592 |
Gender (male VS female) | 1.056 | (0.758, 1.389) | 0.635 | 1.235 | (0.913-1.508) | 0.312 |
ECOG PS (0 VS 1) | 1.932 | (1.213-2.567) | <0.001 | 1.618 | (1.264-2.108) | 0.005 |
Site of primary tumor (head VS body and tail) | 0.59 | (0.198, 1.347) | 0.287 | 0.866 | (0.594-1.096) | 0.461 |
Size of primary tumor (cm) (≥5 VS. <5) | 1.74 | (1.37, 1.825) | 0.059 | 1.155 | (0.906-1.499) | 0.307 |
Histopathological grading (high VS intermediate and low) | 1.896 | (1.389-2.620) | <0.001 | 1.727 | (1.314-2.323) | 0.002 |
TNM stage (I and II VS III) | 2.285 | (1.94-3.05) | <0.001 | 2.104 | (1.488-2.564) | 0.001 |
CD163 (high VS low) | 1.718 | (1.325-2.236) | 0.002 | 1.522 | (1.104-1.992) | 0.012 |
MARCO (high VS low) | 1.598 | (1.119-2.207) | 0.003 | 1.486 | (1.079-1.913) | 0.015 |
CD163/MARCO (double high VS others) | 1.635 | (1.056-2.314) | 0.0025 | 1.408 | (0.998-1.875) | 0.017 |